H2020FP7HORIZON
Academisch Ziekenhuis Leiden
- Country
- NLNetherlands
- Defence projects
- 0
- Projects, all programmes
- 336
- As coordinator
- 102
- EU contribution (CORDIS)
- EUR 216,538,375
- Active
- 2008 to 2026
Projects
336 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| CARTARDISIdentification and validation of novel pharmaceutical drug targets for cardiovascular disease | FP7 | 2013 | Participant | EUR 300,720 |
| T-CONTROLDonor T Cells for Immune Control | FP7 | 2013 | Participant | EUR 935,110 |
| AGORAATMP GMP Open Access Research Alliance - AGORA | FP7 | 2013 | Participant | EUR 29,853 |
| EUC²LIDEuropean Lead Factory | FP7 | 2013 | Participant | EUR 395,721 |
| SURVIVEIntegrating cancer detection and SURgery Via molecular Imaging | FP7 | 2013 | Coordinator | EUR 2,487,600 |
| EURIPREDEuropean Research Infrastructures for Poverty Related Diseases | FP7 | 2013 | Participant | EUR 513,476 |
| SITHProteomic segmentation of intratumour heterogeneity for identifying clinically relevant tumour subpopulations in gastrointestinal cancers | FP7 | 2013 | Coordinator | EUR 175,975 |
| CENTER-TBICollaborative European NeuroTrauma Effectiveness Research in TBI | FP7 | 2013 | Participant | EUR 163,858 |
| BIOIMAGE-NMDBIOIMAGE-Neuromuscular Diseases | FP7 | 2013 | Participant | EUR 573,055 |
| REACHbioREACtor for stem cell tHerapy | FP7 | 2013 | Coordinator | EUR 1,123,915 |
| MyasterixClinical safety, immunogenicity and efficacy of a therapeutic vaccine that combines peptides mimicking antigen receptors on autoimmune B and T cells associated with myasthenia gravis | FP7 | 2013 | Participant | EUR 1,061,596 |
| EECEURO EWING Consortium – International Clinical Trials to Improve Survival from Ewing Sarcoma | FP7 | 2013 | Participant | EUR 75,583 |
| DECODINGSUMOCracking the SUMO Signalling Code | FP7 | 2013 | Coordinator | EUR 1,517,699 |
| BBMRI-LPCBBMRI - Large Prospective Cohorts | FP7 | 2013 | Participant | EUR 288,682 |
| 3GB-TESTIntroducing diagnostic applications of ‘3Gb-testing’ in human genetics | FP7 | 2013 | Coordinator | EUR 85,921 |
| SCOPE-DMDConsortium for Products across Europe in Duchenne Muscular Dystrophy | FP7 | 2013 | Participant | EUR 414,006 |
| HBPThe Human Brain Project | FP7 | 2013 | Participant | EUR 234,000 |
| HPSCLQTHuman pluripotent stem cells for modeling and correcting long-QT syndrome | FP7 | 2012 | Coordinator | EUR 183,806 |
| DIRECTDIabetes REsearCh on patient sTratification | FP7 | 2012 | Participant | EUR 543,444 |
| RISK - IRRisk, Stem Cells and Tissue Kinetics – Ionising Radiation | FP7 | 2012 | Participant | EUR 622,520 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.